Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) Return on Assets (2022 - 2025)

Historic Return on Assets for Prime Medicine (PRME) over the last 4 years, with Q3 2025 value amounting to 0.6%.

  • Prime Medicine's Return on Assets rose 1400.0% to 0.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.8% for FY2024, which is 800.0% down from last year.
  • Per Prime Medicine's latest filing, its Return on Assets stood at 0.6% for Q3 2025, which was up 1400.0% from 0.66% recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Return on Assets ranged from a high of 0.41% in Q1 2023 and a low of 0.92% during Q4 2023
  • In the last 4 years, Prime Medicine's Return on Assets had a median value of 0.65% in 2025 and averaged 0.65%.
  • In the last 5 years, Prime Medicine's Return on Assets crashed by -4900bps in 2023 and then soared by 2900bps in 2024.
  • Prime Medicine's Return on Assets (Quarter) stood at 0.42% in 2022, then plummeted by -116bps to 0.92% in 2023, then surged by 32bps to 0.62% in 2024, then grew by 3bps to 0.6% in 2025.
  • Its Return on Assets was 0.6% in Q3 2025, compared to 0.66% in Q2 2025 and 0.65% in Q1 2025.